Aehr Test Systems (NASDAQ:AEHR – Get Free Report) Director Rhea Posedel sold 7,500 shares of the company’s stock in a transaction on Friday, April 17th. The shares were sold at an average price of $82.00, for a total value of $615,000.00. Following the sale, the director owned 404,479 shares of the company’s stock, valued at approximately $33,167,278. This trade represents a 1.82% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.
Aehr Test Systems Stock Performance
Aehr Test Systems stock opened at $83.86 on Friday. The stock has a market cap of $2.64 billion, a PE ratio of -220.68 and a beta of 2.28. Aehr Test Systems has a one year low of $7.71 and a one year high of $91.43. The stock has a fifty day moving average of $42.81 and a 200 day moving average of $31.03.
Aehr Test Systems (NASDAQ:AEHR – Get Free Report) last posted its quarterly earnings data on Tuesday, April 7th. The semiconductor company reported ($0.05) EPS for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.02. The company had revenue of $10.31 million during the quarter, compared to analysts’ expectations of $10.85 million. Aehr Test Systems had a negative return on equity of 7.15% and a negative net margin of 25.23%. As a group, sell-side analysts predict that Aehr Test Systems will post 0.1 EPS for the current fiscal year.
Analysts Set New Price Targets
Read Our Latest Research Report on Aehr Test Systems
Trending Headlines about Aehr Test Systems
Here are the key news stories impacting Aehr Test Systems this week:
- Positive Sentiment: Record $41M hyperscale AI production order — the follow‑on order is for package‑level burn‑in of custom AI ASICs and is described as the largest in company history, providing a clear near‑term revenue and capacity catalyst. Accesswire: Record $41M order
- Positive Sentiment: Bookings/backlog strength tied to AI/data‑center demand — company updates and coverage report second‑half bookings exceeding ~$92M and a record backlog, supporting upside to FY2027 revenue if orders convert. Benzinga: record deal & bookings
- Positive Sentiment: Analyst optimism and higher price targets — recent upgrades and bumped targets have reinforced investor interest and helped attract institutional/retail flows. MSN: price target increase
- Positive Sentiment: Technical/momentum factors may amplify moves — a recent golden‑cross and elevated short interest increase the likelihood of follow‑through and short covering when positive headlines arrive. Seeking Alpha: movers summary
- Neutral Sentiment: Volatility and coverage: several outlets note extreme YTD moves (one headline cites a 300% move) — useful as context for sentiment but not a direct fundamental change. InsiderMonkey: AEHR up 300%
- Neutral Sentiment: Mixed quarterly fundamentals — AEHR beat EPS slightly but missed revenue; execution to convert large bookings into sustained, profitable growth remains the key risk. MarketBeat: quarterly results
- Negative Sentiment: Clustered insider selling — multiple executives and directors disclosed sizable share sales (including director and C‑suite transactions in mid‑April), which can create near‑term selling pressure and raise investor questions about insider conviction. InsiderTrades: insider selling
- Negative Sentiment: Media and aggregation highlight insider liquidity events — coverage emphasizing millions in insider proceeds can weigh on sentiment even if some sales are routine or for tax purposes. TipRanks: insider sell-off
Institutional Trading of Aehr Test Systems
A number of hedge funds and other institutional investors have recently bought and sold shares of AEHR. Vanguard Group Inc. boosted its stake in shares of Aehr Test Systems by 2.9% in the third quarter. Vanguard Group Inc. now owns 2,288,190 shares of the semiconductor company’s stock worth $68,897,000 after acquiring an additional 65,444 shares during the period. KLCM Advisors Inc. boosted its stake in shares of Aehr Test Systems by 200.0% in the third quarter. KLCM Advisors Inc. now owns 75,000 shares of the semiconductor company’s stock worth $2,258,000 after acquiring an additional 50,000 shares during the period. HighTower Advisors LLC boosted its stake in shares of Aehr Test Systems by 485.1% in the third quarter. HighTower Advisors LLC now owns 78,340 shares of the semiconductor company’s stock worth $2,359,000 after acquiring an additional 64,950 shares during the period. William Blair Investment Management LLC bought a new position in shares of Aehr Test Systems in the third quarter worth about $26,920,000. Finally, Fortitude Advisory Group L.L.C. bought a new position in shares of Aehr Test Systems in the third quarter worth about $671,000. Hedge funds and other institutional investors own 69.69% of the company’s stock.
Aehr Test Systems Company Profile
Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.
The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.
Further Reading
Receive News & Ratings for Aehr Test Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aehr Test Systems and related companies with MarketBeat.com's FREE daily email newsletter.
